Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance

[1] Gianolio E(2017)Gadolinium Retention in the Rat Brain: assessment of the amounts of insoluble gadolinium-containing species and intact gadolinium complexes after repeated administration of gadolinium-based contrast agents Radiology 285 839-849

[2] Bardini P(2015)Intracranial gadolinium deposition after contrast-enhanced MR imaging Radiology 275 772-782

[3] Arena F(2017)Comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates Radiology 285 536-545

[4] Stefania R(2015)Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy Radiology 276 228-232

[5] Di Gregorio E(2006)Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review Fundamental & Clin Pharm 20 563-576

[6] Iani R(1996)Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats AJNR Am J Neuroradiol 17 365-373

[7] McDonald RJ(2005)Gadolinium encephalopathy in a patient with renal failure Neurology 64 1276-1278

[8] McDonald JS(2013)Gadolinium induced recurrent acute pancreatitis Pancreatology 13 88-89

[9] Kallmes DF(2006)Are gadolinium-based contrast media nephrotoxic? A renal biopsy study Arch Path Lab Med 130 1354-1357

[10] Jentoft ME(2016)Brain gadolinium deposition after administration of gadolinium-based contrast agents Jpn J Radiol 34 3-9

[1] Gianolio E(2017)Gadolinium Retention in the Rat Brain: assessment of the amounts of insoluble gadolinium-containing species and intact gadolinium complexes after repeated administration of gadolinium-based contrast agents Radiology 285 839-849

[2] Bardini P(2015)Intracranial gadolinium deposition after contrast-enhanced MR imaging Radiology 275 772-782

[3] Arena F(2017)Comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates Radiology 285 536-545

[4] Stefania R(2015)Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy Radiology 276 228-232

[5] Di Gregorio E(2006)Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review Fundamental & Clin Pharm 20 563-576

[6] Iani R(1996)Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats AJNR Am J Neuroradiol 17 365-373

[7] McDonald RJ(2005)Gadolinium encephalopathy in a patient with renal failure Neurology 64 1276-1278

[8] McDonald JS(2013)Gadolinium induced recurrent acute pancreatitis Pancreatology 13 88-89

[9] Kallmes DF(2006)Are gadolinium-based contrast media nephrotoxic? A renal biopsy study Arch Path Lab Med 130 1354-1357

[10] Jentoft ME(2016)Brain gadolinium deposition after administration of gadolinium-based contrast agents Jpn J Radiol 34 3-9